CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 4 Open-market sale CEO and Chairman sold 49,560 shares at an average $59.88 ($2,967,819)
- 4 Open-market sale President sold 45,000 shares at an average $60.49 ($2,722,179)
- 4 Open-market sale President sold 15,000 shares at an average $63.53 ($953,015)
- 4 Open-market sale President sold 45,000 shares at an average $62.47 ($2,810,983)
- 4 Open-market sale EVP, Operations & Program Mana sold 57,000 shares at an average $63.71 ($3,631,702)
- 4 Open-market sale Director sold 25,000 shares at $60.00 ($1,500,000)
- 4 Open-market sale Chief Business Development Off sold 417 shares at $59.14 ($24,661)
- 4 Open-market sale 10% owner sold 1,000,000 shares at $55.65 ($55,650,000)
- 4 Open-market sale EVP, Operations & Program Mana sold 40,000 shares at $59.00 ($2,360,000)
- 4 Open-market sale Director sold 2,000 shares at an average $55.93 ($111,856)
- 4 Open-market sale Director sold 6,000 shares at an average $58.84 ($353,040)
- 4 Open-market sale Chief People Officer sold 2,000 shares at an average $55.94 ($111,874)
- 4 Open-market sale SVP, External Affairs sold 50,000 shares at $56.13 ($2,806,500)
- 4 Open-market sale SVP, Diagnostics, clonoSEQ sold 25,000 shares at $55.00 ($1,375,000)
- 4 Open-market sale Chief Medical Officer sold 6,250 shares at an average $50.41 ($315,088)
- 4 Open-market sale Chief Financial Officer sold 30,000 shares at an average $51.24 ($1,537,238)
- 4 Open-market sale Chief Business Development Off sold 6,770 shares at an average $48.87 ($330,856)
- 4 Open-market sale SVP and General Counsel sold 2,880 shares at an average $46.31 ($133,359)
- 4 Open-market sale Chief Business Development Off sold 416 shares at $48.86 ($20,326)
- 4 Open-market sale CEO and Chairman sold 50,040 shares at an average $46.99 ($2,351,429)
Page 29 of 42 · 837 filings